AU4722197A - Novel remedies for infectious diseases - Google Patents

Novel remedies for infectious diseases

Info

Publication number
AU4722197A
AU4722197A AU47221/97A AU4722197A AU4722197A AU 4722197 A AU4722197 A AU 4722197A AU 47221/97 A AU47221/97 A AU 47221/97A AU 4722197 A AU4722197 A AU 4722197A AU 4722197 A AU4722197 A AU 4722197A
Authority
AU
Australia
Prior art keywords
infectious diseases
novel remedies
remedies
novel
infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47221/97A
Inventor
Hiroaki Inagaki
Yohhei Ishida
Kiyoshi Nakayama
Toshiyuki Nishi
Toshiharu Ohta
Masami Ohtsuka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU4722197A publication Critical patent/AU4722197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
AU47221/97A 1996-10-22 1997-10-22 Novel remedies for infectious diseases Abandoned AU4722197A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP27917296 1996-10-22
JP8-279172 1996-10-22
JP28720396 1996-10-30
JP8-287203 1996-10-30
PCT/JP1997/003812 WO1998017625A1 (en) 1996-10-22 1997-10-22 Novel remedies for infectious diseases

Publications (1)

Publication Number Publication Date
AU4722197A true AU4722197A (en) 1998-05-15

Family

ID=26553201

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47221/97A Abandoned AU4722197A (en) 1996-10-22 1997-10-22 Novel remedies for infectious diseases

Country Status (3)

Country Link
JP (1) JP4024309B2 (en)
AU (1) AU4722197A (en)
WO (1) WO1998017625A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046569A1 (en) * 1997-04-11 1998-10-22 Sumitomo Pharmaceuticals Co., Ltd. Benzene derivatives
US6399629B1 (en) 1998-06-01 2002-06-04 Microcide Pharmaceuticals, Inc. Efflux pump inhibitors
EP1227084B1 (en) * 1999-10-28 2005-12-14 Trine Pharmaceuticals, Inc. Drug discharge pump inhibitors
US6143776A (en) * 2000-02-02 2000-11-07 Sunesis Pharmaceuticals, Inc. Tosylproline analogs as thymidylate synthase inhibitors
DE60228941D1 (en) 2001-03-08 2008-10-30 Univ Pennsylvania Faciale amphiphile polymere als antiinfektiöse mittel
JPWO2002087589A1 (en) * 2001-04-26 2004-08-12 第一製薬株式会社 Drug efflux pump inhibitor
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
JP2002322054A (en) * 2001-04-26 2002-11-08 Dai Ichi Seiyaku Co Ltd Drug discharging pump inhibitor
JP2005504043A (en) * 2001-08-10 2005-02-10 パラチン テクノロジーズ インク． Peptidomimetics of biologically active metal peptides
ES2292931T3 (en) * 2002-02-01 2008-03-16 Novo Nordisk A/S AMIDAS OF AZETIDINS, PIRROLIDINES, PIPERIDINES AND AZEPANOS AMINOALQUILO REPLACED.
AU2004222272B2 (en) 2003-03-17 2010-12-23 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof
US7507760B2 (en) * 2004-01-22 2009-03-24 Neuromed Pharmaceuticals Ltd. N-type calcium channel blockers
CA2554163A1 (en) 2004-01-23 2005-08-11 The Trustees Of The University Of Pennsylvania Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
WO2006067862A1 (en) * 2004-12-22 2006-06-29 The Kitasato Institute Active substances k03-0132 and method of producing the same
WO2006075395A1 (en) * 2005-01-11 2006-07-20 The Kitasato Institute β-LACTAM ANTIBIOTIC ACTIVITY ENHANCER AND PROCESS FOR PRODUCING THE SAME
PL1966130T3 (en) * 2005-12-23 2014-05-30 Zealand Pharma As Modified lysine-mimetic compounds
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
AU2008210434C8 (en) 2007-01-31 2014-03-27 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
BRPI0809366B8 (en) 2007-03-28 2021-05-25 Harvard College substantially alpha-helical polypeptide, method for manufacturing same, amino acid and pharmaceutical composition
TWI433838B (en) 2008-06-25 2014-04-11 必治妥美雅史谷比公司 Piperidinyl derivative as a modulator of chemokine receptor activity
GB0813144D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
GB0813142D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
US8642622B2 (en) 2010-06-16 2014-02-04 Bristol-Myers Squibb Company Piperidinyl compound as a modulator of chemokine receptor activity
US8859723B2 (en) 2010-08-13 2014-10-14 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN108929375A (en) 2011-10-18 2018-12-04 爱勒让治疗公司 Peptidomimetic macrocyclic compound
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
US8927500B2 (en) 2012-02-15 2015-01-06 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP6526563B2 (en) 2012-11-01 2019-06-05 エイルロン セラピューティクス，インコーポレイテッド Disubstituted amino acids and methods for their preparation and use
SG10201902594QA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
US10905739B2 (en) 2014-09-24 2021-02-02 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
MX2017011834A (en) 2015-03-20 2018-04-11 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof.
EP3347372A4 (en) 2015-09-10 2019-09-04 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of mcl-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS495930A (en) * 1972-05-10 1974-01-19
JPS495931A (en) * 1972-05-11 1974-01-19
HUT40429A (en) * 1985-04-29 1986-12-28 Chinoin Gyogyszer Es Vegyeszet Process for production of salts of derivatives of kynolin carbonic acid
JPH04211077A (en) * 1990-02-19 1992-08-03 Kyorin Pharmaceut Co Ltd Optically active 8-methoxyquinolonecarboxylic acid derivative, its production and intermediate
CA2074061A1 (en) * 1991-08-26 1993-02-27 Ivo Monkovic Benzamide multidrug resistance reversing agents
US5371076A (en) * 1993-04-02 1994-12-06 American Cyanamid Company 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
JPH0769873A (en) * 1993-09-01 1995-03-14 Yuki Gosei Kogyo Co Ltd Sterilizing and disinfecting agent for pseudomonas aeruginosa
JPH0967250A (en) * 1995-08-31 1997-03-11 Hoechst Japan Ltd Therapeutic agent for methicillin resistant staphylococcus aureus infection
JPH09100261A (en) * 1995-10-03 1997-04-15 Banyu Pharmaceut Co Ltd Antimicrobial substance be-44651

Also Published As

Publication number Publication date
JP4024309B2 (en) 2007-12-19
WO1998017625A1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
AU4722197A (en) Novel remedies for infectious diseases
AU651790B3 (en) Scalpel
EP0796628A3 (en) Inhaler
AU3532195A (en) Medicaments
AU2979795A (en) Tampon
AU689235B2 (en) Remedy for infectious diseases
AU2654299A (en) Wheelchair
AUPM740594A0 (en) Anti-inflammatory preparation
AU4267396A (en) Modified cannula
AU2523795A (en) Inhaler
AU3154395A (en) Contraceptive vaccine
AU4330097A (en) Pharmaceutical compounds
AU2769595A (en) Contraceptive vaccine
AU2025395A (en) Sustained release preparations
AU3181597A (en) Can shaping
AU3460897A (en) Medicinal compositions
AU9001698A (en) Remedies for hormone-dependent diseases
AU4344996A (en) Vessel-puncturing cannula
AU4169897A (en) Pharmaceutical compounds
AU1475595A (en) Pharmaceutical preparation
AU3619695A (en) Thioquinolone derivative
AU2629295A (en) Trifluoromethylquinolinecarboxylic acid derivative
AU2043295A (en) Antiulcer drug
AU3156595A (en) Anti-inflammatory preparation
AU3885995A (en) Novel medicinal use